James Cassella
Director/Board Member at TREVI THERAPEUTICS, INC.
Net worth: - $ as of 2024-03-30
Profile
James V.
Cassella is an Independent Director at Trevi Therapeutics, Inc. and the Chief Development Officer & Senior Vice President at Concert Pharmaceuticals, Inc. He was previously the Senior VP-Clinical Research & Development at Neurogen Corp.
from 1989 to 2004 and the CSO, Executive VP-Research & Development at Alexza Pharmaceuticals, Inc. from 2013 to 2015.
He also worked as an Assistant Professor at Oberlin College.
Cassella holds a doctorate degree from Dartmouth College and an undergraduate degree from the University of New Haven.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TREVI THERAPEUTICS, INC.
-.--% | 2023-06-27 | 0 ( -.--% ) | - $ | 2024-03-30 |
James Cassella active positions
| Companies | Position | Start |
|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2015-02-03 |
| TREVI THERAPEUTICS, INC. | Director/Board Member | 2020-02-12 |
Former positions of James Cassella
| Companies | Position | End |
|---|---|---|
| ALEXZA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2015-01-28 |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Corporate Officer/Principal | 2004-05-31 |
| Oberlin College | Corporate Officer/Principal | - |
Training of James Cassella
| Dartmouth College | Doctorate Degree |
| University of New Haven | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- James Cassella
